Malvern Institute

Stay Connected With Malvern. Get Email Updates

info@malverninstitute.com | Follow Us:

Philly sues opioid makers in response to health crisis

January 18, 2018 – There is no single reason why the drug epidemic has affected so many individuals struggling with the disease of addiction. However, it’s important to address factors when they can be identified.

This week, the city of Philadelphia accused major opioid manufacturers of “deceptive marketing of prescription opioids” in a lawsuit. City health officials claim the companies’ practice has contributed to the public health crisis.

The city wants to recover costs related to responding to the opioid epidemic, including paying first responders and bolstering funding for public health programs and other departments affected by the drug crisis.

More from NBC Philadelphia:

“The epidemic currently plaguing the city has exacted a grim toll on Philadelphia residents and their families,” [Philadelphia Mayor Jim] Kenney said. “And the cause can be directly linked to methods used by manufacturers to market and sell their products to doctors and the public. Those tactics have to end.”

The number of deadly overdoses in Philadelphia in 2017 is expected to reach 1,200, one-third more than 2016. The Centers for Disease Control and Prevention says Philadelphia suffered a higher rate of overdose deaths than any other major American city.

Malvern Institute: We Give Hope

If you or a loved one are living with addiction, we can help. Learn about Malvern Intervention Services or the Malvern 90-Day Model by calling 610.MALVERN (610.625.8376).

Read the full story on NBC Philadelphia.

Testimonials

Recent News

Podcast tackles science behind addiction treatment, opioid epidemic

March 30, 2018 – Raising awareness of the facts about the disease of addiction and breaking the stigma associated with addiction are necessary steps toward truly helping families affected by the disease of addiction. This month, Gimlet Media’s “Science Vs.” podcast released two episodes dedi...

Read More

See All News

© 2017 Malvern Institute - All Rights Reserved | View Privacy Policy